CHLOE SCHAUFENBUEL: Open Payments
NPI 1801670542 · WATERLOO, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,319 in 85 payments from 13 companies in 2025. Trend: 2023 $241 · 2024 $1,487 · 2025 $1,319
Food & beverage: $1,319
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 26 | $296 |
| PFIZER INC. | 11 | $203 |
| E.R. Squibb & Sons, L.L.C. | 10 | $138 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 9 | $135 |
| Merck Sharp & Dohme LLC | 6 | $117 |
| Novo Nordisk Inc | 6 | $113 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $83 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $71 |
| SCPHARMACEUTICALS INC. | 2 | $39 |
| BridgeBio Pharma, Inc. | 2 | $37 |
Products named: LEQVIO, LifeVest, CAMZYOS, VYNDAQEL, Wegovy, ELIQUIS, ENTRESTO, VERQUVO.
Industry payments across IA — which companies pay providers there.
